Aymeric Sallin, founder and CEO of +ND Capital (formerly NanoDimension). See sector focus and contact routes.
Aymeric Sallin, founder and CEO of +ND Capital (formerly NanoDimension), invests $100K–$5M in pre-seed through Series B ventures across biotech, AI, therapeutics, health IT, digital health, and healthcare services. His firm targets “disruptive technologies” at the convergence of life, physical, and data sciences, with a global portfolio in cutting-edge health and technology. Notable portfolio companies include Tarveda Therapeutics, Selecta Biosciences, Crocus Technology, Natron Energy, SiMa.ai, and H55. Sallin is a long-standing life sciences investor with board seats at biopharma and advanced technology firms, emphasizing domain expertise and commercialization strategy.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Woodside when building a target list.
Investors like Aymeric Sallin · Full investor directory · Investor access · Company funding database